Michael F. Cola

Filings by Michael F. Cola span 4 companies, the busiest being Phathom Pharmaceuticals, Inc., Aevi Genomic Medicine, LLC and Vanda Pharmaceuticals Inc. Over a trading history stretching from 15 June 2017 to 19 May 2026, the count stands at 14 filings.

No open-market sale appears; the market trades are 5 purchases worth €984k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 8 share grants.

Half of the purchases are above €221k and half below. 3 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 21 May 2026 came the latest disclosure, a share grant in Phathom Pharmaceuticals, Inc. The clock since the last published purchase (18 February 2022) now reads 1,709 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.